Skip to main content

Table 3 Costs of all pharmaceuticals used by patients treated for COPD in Denmark 2016

From: Healthcare costs of patients with chronic obstructive pulmonary disease in Denmark – specialist care versus GP care only

COPD care level five years back: GP care only (reference) Specialist care at least once Comparison
Drug target (ATC codes) Cost total in 1000 Costs / pt. year in % Cost total in 1000 Costs / pt. year in % CoefAdj (95%CI)
All pharmaceuticals, total (A00-V20) 93,208 1,383 100 81,942 1,876 100 1.28(1.28–1.28)
Respiratory organs (R* & V01) 52,768 783 56.6 45,009 1,030 54.9 1.21(1.21–1.22)
Coagulation or blood (B*) 5,795 86 6.2 6,087 139 7.4 1.49(1.49–1.49)
Neurology or psychiatry (N03-99) 6,515 97 7.0 5,824 133 7.1 1.47(1.47–1.47)
Pain, muscles, joints (N00-02 & M01-09c) 5,358 79 5.7 5,142 118 6.3 1.47(1.47–1.48)
Diabetes (A10) 4,543 67 4.9 3,808 87 4.6 1.32(1.32–1.32)
Hypertension or heart (C00-09b) 4,123 61 4.4 3,523 81 4.3 1.24(1.24–1.24)
Other digestive system (A00-16d) 2,602 39 2.8 2,946 67 3.6 1.64(1.63–1.64)
Infection (J* & P*) 2,178 32 2.3 2,669 61 3.3 1.80(1.79–1.80)
Thyroid and not-sex hormones (H*) 1,299 19 1.4 1,408 32 1.7 1.59(1.58–1.59)
Urologic disease (G04) 1,531 23 1.6 1,048 24 1.3 1.00(0.99–1.00)
Hyperlipidaemia (C10) 1,749 26 1.9 1,028 24 1.3 0.91(0.91–0.91)
Eyes and ears (S*) 1,123 17 1.2 785 18 1.0 0.97(0.97–0.97)
Gastric acid (A02) 716 11 0.8 601 14 0.7 1.26(1.25–1.26)
Female organs or hormones (G01-03) 923 14 1.0 528 12 0.6 0.86(0.85–0.86)
Dermatology (D*) 702 10 0.8 525 12 0.6 1.11(1.11–1.12)
Osteoporosis (M05) 530 8 0.6 514 12 0.6 1.37(1.36–1.38)
Neoplasms or immune system (L*) 309 5 0.3 120 3 0.1 0.59(0.59–0.60)
Others 444 7 0.5 377 9 0.5 1.41(1.40–1.41)
  1. Abbreviations: COPD chronic obstructive pulmonary disease defined; R03 is the anatomical therapeutical chemical code for drugs targeting obstructive lung diseases; b excluding C05A; c excluding M05; d including C05A and excluding A02 and A10; CoefAdj Sex- and age-adjusted coefficient, CI Confidence interval